Literature DB >> 29029143

Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry.

Lesley-Ann Gray1,2, Heather A D'Antoine3, Steven Y C Tong3,4, Melita McKinnon3, Dawn Bessarab5, Ngiare Brown6, Bo Reményi3, Andrew Steer7,8, Genevieve Syn9, Jenefer M Blackwell9, Michael Inouye1,2, Jonathan R Carapetis3,9.   

Abstract

Background: Rheumatic heart disease (RHD) after group A streptococcus (GAS) infections is heritable and prevalent in Indigenous populations. Molecular mimicry between human and GAS proteins triggers proinflammatory cardiac valve-reactive T cells.
Methods: Genome-wide genetic analysis was undertaken in 1263 Aboriginal Australians (398 RHD cases; 865 controls). Single-nucleotide polymorphisms were genotyped using Illumina HumanCoreExome BeadChips. Direct typing and imputation was used to fine-map the human leukocyte antigen (HLA) region. Epitope binding affinities were mapped for human cross-reactive GAS proteins, including M5 and M6.
Results: The strongest genetic association was intronic to HLA-DQA1 (rs9272622; P = 1.86 × 10-7). Conditional analyses showed rs9272622 and/or DQA1*AA16 account for the HLA signal. HLA-DQA1*0101_DQB1*0503 (odds ratio [OR], 1.44; 95% confidence interval [CI], 1.09-1.90; P = 9.56 × 10-3) and HLA-DQA1*0103_DQB1*0601 (OR, 1.27; 95% CI, 1.07-1.52; P = 7.15 × 10-3) were risk haplotypes; HLA_DQA1*0301-DQB1*0402 (OR 0.30, 95%CI 0.14-0.65, P = 2.36 × 10-3) was protective. Human myosin cross-reactive N-terminal and B repeat epitopes of GAS M5/M6 bind with higher affinity to DQA1/DQB1 alpha/beta dimers for the 2-risk haplotypes than the protective haplotype. Conclusions: Variation at HLA_DQA1-DQB1 is the major genetic risk factor for RHD in Aboriginal Australians studied here. Cross-reactive epitopes bind with higher affinity to alpha/beta dimers formed by risk haplotypes, supporting molecular mimicry as the key mechanism of RHD pathogenesis.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  GWAS; HLA; acute rheumatic fever; epitope mapping; rheumatic heart disease

Mesh:

Substances:

Year:  2017        PMID: 29029143     DOI: 10.1093/infdis/jix497

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

Review 2.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 3.  Genetics of rheumatic fever and rheumatic heart disease.

Authors:  Babu Muhamed; Tom Parks; Karen Sliwa
Journal:  Nat Rev Cardiol       Date:  2019-09-13       Impact factor: 32.419

Review 4.  Rheumatic heart disease: infectious disease origin, chronic care approach.

Authors:  Judith M Katzenellenbogen; Anna P Ralph; Rosemary Wyber; Jonathan R Carapetis
Journal:  BMC Health Serv Res       Date:  2017-11-29       Impact factor: 2.655

5.  How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.

Authors:  Jessica Langloh de Dassel; Nick de Klerk; Jonathan Rhys Carapetis; Anna P Ralph
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

6.  Reference exome data for Australian Aboriginal populations to support health-based research.

Authors:  Jenefer M Blackwell; Timo Lassmann; Alexia L Weeks; Heather A D'Antoine; Melita McKinnon; Genevieve Syn; Dawn Bessarab; Ngiare Brown; Steven Y C Tong; Bo Reményi; Andrew Steer; Lesley-Ann Gray; Michael Inouye; Jonathan R Carapetis
Journal:  Sci Data       Date:  2020-04-29       Impact factor: 6.444

Review 7.  Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand.

Authors:  Michael G Baker; Jason Gurney; Jane Oliver; Nicole J Moreland; Deborah A Williamson; Nevil Pierse; Nigel Wilson; Tony R Merriman; Teuila Percival; Colleen Murray; Catherine Jackson; Richard Edwards; Lyndie Foster Page; Florina Chan Mow; Angela Chong; Barry Gribben; Diana Lennon
Journal:  Int J Environ Res Public Health       Date:  2019-11-15       Impact factor: 3.390

Review 8.  Streptococcus pyogenes ("Group A Streptococcus"), a Highly Adapted Human Pathogen-Potential Implications of Its Virulence Regulation for Epidemiology and Disease Management.

Authors:  Nikolai Siemens; Rudolf Lütticken
Journal:  Pathogens       Date:  2021-06-21

Review 9.  The "Cairo Accord"- Towards the Eradication of RHD: An Update.

Authors:  Susy Kotit; David I W Phillips; Ahmed Afifi; Magdi Yacoub
Journal:  Front Cardiovasc Med       Date:  2021-07-02

10.  The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans.

Authors:  Kathryn Auckland; Balraj Mittal; Benjamin J Cairns; Naveen Garg; Surendra Kumar; Alexander J Mentzer; Joseph Kado; Mai Ling Perman; Andrew C Steer; Adrian V S Hill; Tom Parks
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.